Amlodipine/Simvastatin

氨氯地平/辛伐他汀

Report date: 2022/03/08 16:45:19

Base Information

Drug NameAmlodipine/Simvastatin
Drug Alias Name辛伐他汀/氨氯地平Amlodipine Besylate/Simvastatin苯磺酸氨氯地平+辛伐他汀Amlodipine Besylate+Simvastatin苯磺酸氨氯地平/辛伐他汀 +[11] 
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated calcium channel blockersHMG-CoA reductase inhibitors
TargetsVoltage-gated calcium channelHMG-CoA reductase
Therapy Area/IndicationsHyperlipidemiasHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Amlodipine BesylateSimvastatin
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHanall
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHanallBernofarm
Active IndicationsN/A
Inactive IndicationsHyperlipidemiasHypertension

Other Information

ATC CodeN/A
Related LinksN/A